These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 22100028

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women.
    Uemura H, Yasui T, Miyatani Y, Yamada M, Hiyoshi M, Arisawa K, Irahara M.
    Menopause; 2008; 15(1):180-4. PubMed ID: 17545921
    [Abstract] [Full Text] [Related]

  • 27. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
    Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH.
    Circulation; 2004 Feb 24; 109(7):843-8. PubMed ID: 14757688
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes.
    Altinova AE, Toruner F, Akturk M, Bukan N, Yetkin I, Cakir N, Arslan M.
    Scand J Clin Lab Invest; 2011 Jul 24; 71(4):340-3. PubMed ID: 21486111
    [Abstract] [Full Text] [Related]

  • 30. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH, Fares F, Semaan M, Khalife S, Jambart S.
    Clin Endocrinol (Oxf); 2006 Jun 24; 64(6):652-8. PubMed ID: 16712667
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.
    Wick PA, Mombelli A, Pagano S, Moren X, Giannopoulou C, Mach F, Roux-Lombard P, Vuilleumier N.
    J Periodontal Res; 2013 Jun 24; 48(3):350-6. PubMed ID: 23050768
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role?
    Pennisi P, Russo E, Gaudio A, Veca R, D'Amico F, Mangiafico RA, Laspina M, Tringali G, Signorelli SS, Fiore CE.
    Maturitas; 2010 Dec 24; 67(4):358-62. PubMed ID: 20727694
    [Abstract] [Full Text] [Related]

  • 39. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.
    Yu HI, Sheu WH, Song YM, Liu HC, Lee WJ, Chen YT.
    Diabet Med; 2004 Apr 24; 21(4):336-41. PubMed ID: 15049935
    [Abstract] [Full Text] [Related]

  • 40. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.
    Arch Intern Med; 1996 Jun 10; 156(11):1181-8. PubMed ID: 8639012
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.